InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 22.41
+0.87 (4.04%)
At close: Jul 10, 2026
InventisBio Market Cap
InventisBio has a market cap or net worth of 12.96 billion as of July 10, 2026. Its market cap has decreased by -35.64% in one year.
Market Cap
12.96B
Enterprise Value
11.60B
Revenue
71.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.41
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 12.96B, an increase of 47.42%. That is a compound annual growth rate of 10.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 12.96B | -17.73% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HitGen | 14.37B |
| Anhui Anke Biotechnology (Group) | 13.72B |
| Mabwell (Shanghai) Bioscience | 13.66B |
| BrightGene Bio-Medical Technology | 13.57B |
| Jinyu Bio-technology | 13.31B |
| Staidson (Beijing) BioPharmaceuticals | 11.57B |
| Shanghai Medicilon | 11.44B |
| Inner Mongolia Furui Medical Science | 11.42B |